Valuation: 3SBio Inc.

Market Cap 26.98B 31.68B 4.04B 3.68B 3.39B 3.09B 5.79B 374B 6.08B 41.28B 16.41B 204B 15.17B 14.85B 642B P/E 2026 *
11.5x
P/E 2027 * 11.1x
Enterprise Value 15.95B 18.72B 2.39B 2.18B 2.01B 1.82B 3.42B 221B 3.6B 24.4B 9.7B 121B 8.96B 8.78B 379B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.5x
Free-Float
74.29%
Yield 2026 *
2.09%
Yield 2027 * 2.28%
1 day-3.64%
1 week-11.98%
Current month-6.13%
1 month-11.06%
3 months-28.72%
6 months-33.03%
Current year-47.44%
1 week 12.48
Extreme 12.48
14.44
1 month 12.48
Extreme 12.48
15.64
Current year 12.48
Extreme 12.48
29.3
1 year 12.48
Extreme 12.48
32.8
3 years 4.91
Extreme 4.91
36.8
5 years 4.72
Extreme 4.72
36.8
10 years 4.72
Extreme 4.72
36.8
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2006
Director of Finance/CFO 43 03/07/2023
Corporate Officer/Principal 56 27/11/2014
Director TitleAgeSince
Chairman 63 03/04/2012
Director/Board Member 56 11/06/2012
Director/Board Member 57 01/06/2015
Date Insider Type Main position Quantity % Market Cap. Importance
9/7/26 A Other

Chief Executive Officer

490,000 0.0193%
7/29/25 A Other

Chief Executive Officer

440,000 0.0184%
4/15/25 A Other

Director

26,000 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-3.64%-11.98%-56.68%+76.53% 4.04B
-0.30%-6.68%+27.12%+127.32% 1,200B
+1.25%-5.35%+32.65%+78.98% 651B
+0.94%-2.99%+21.13%+106.30% 506B
-0.60%-1.95%+25.73%+67.00% 377B
+0.69%-9.50%+36.78%+30.83% 330B
+0.41%-4.70%+24.18%+50.18% 288B
+0.81%-4.08%-2.95%+31.59% 272B
-0.15%-6.45%+29.06%+65.76% 236B
-0.06%-0.98%+31.42%+122.83% 206B
Average -0.07%-5.48%+16.84%+75.73% 407B
Weighted average by Cap. +0.30%-5.20%+25.94%+87.87%

Financials

2026 *2027 *
Net sales 9.31B 10.93B 1.39B 1.27B 1.17B 1.06B 2B 129B 2.1B 14.24B 5.66B 70.54B 5.23B 5.12B 221B 9.69B 11.38B 1.45B 1.32B 1.22B 1.11B 2.08B 134B 2.19B 14.83B 5.89B 73.42B 5.45B 5.33B 230B
Net income 2.37B 2.79B 356M 324M 298M 271M 509M 32.93B 535M 3.63B 1.44B 17.99B 1.33B 1.31B 56.45B 2.49B 2.92B 372M 339M 313M 284M 533M 34.49B 561M 3.8B 1.51B 18.84B 1.4B 1.37B 59.11B
Net Debt -11.03B -12.95B -1.65B -1.51B -1.39B -1.26B -2.37B -153B -2.49B -16.88B -6.71B -83.59B -6.2B -6.07B -262B -12.41B -14.57B -1.86B -1.69B -1.56B -1.42B -2.66B -172B -2.8B -18.99B -7.55B -94.02B -6.97B -6.83B -295B
Projected Income Statement - Annual - 3SBio Inc.
Logo 3SBio Inc.
3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
6,068
Date Price Change Volume
20/11/26 HK$12.71 -3.64% 15,783,742
19/11/26 HK$13.19 -0.83% 9,789,429
18/11/26 HK$13.30 -4.04% 14,574,708
17/11/26 HK$13.86 -1.63% 12,558,126
16/11/26 HK$14.09 -2.42% 19,294,500
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - 3SBio Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
10.83CNY
Average target price
24.57CNY
Spread / Average Target
+126.93%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - 3SBio Inc.
  1. Stock Market
  2. Stocks
  3. 1530 Stock